105 related articles for article (PubMed ID: 7543352)
1. Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Kessinger A; Bishop MR; Anderson JR; Armitage JO; Bierman PJ; Reed EC; Tarantolo S; Tempero MA; Vose JM; Warkentin PI
J Hematother; 1995 Apr; 4(2):81-4. PubMed ID: 7543352
[TBL] [Abstract][Full Text] [Related]
2. Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.
Klingebiel T; Handgretinger R; Herter M; Eppinger T; Bader P; Lang P; Dopfer R; Scheel-Walter H; Haus U; Niethammer D
J Hematother; 1995 Aug; 4(4):307-14. PubMed ID: 7489145
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.
Martínez E; Sureda A; Dalmases CD; Sánchez JA; Amill B; Tugues D; Sardá P; Miralles A; Brunet S; Domingo-Albós A; García J
Bone Marrow Transplant; 1996 Jul; 18(1):1-7. PubMed ID: 8831988
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Bishop MR; Jackson JD; O'Kane-Murphy B; Schmit-Pokorny K; Vose JM; Bierman PJ; Warkentin PI; Armitage JO; Garrison L; Kessinger A
J Clin Oncol; 1996 Sep; 14(9):2521-6. PubMed ID: 8823331
[TBL] [Abstract][Full Text] [Related]
7. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.
Rosenfeld CS; Bolwell B; LeFever A; Taylor R; List A; Fay J; Collins R; Andrews F; Pallansch P; Schuster MW; Resta D; Levitt D; Nemunaitis J
Bone Marrow Transplant; 1996 Feb; 17(2):179-83. PubMed ID: 8640163
[TBL] [Abstract][Full Text] [Related]
9. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
10. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
Ippoliti C; Przepiorka D; Giralt S; Andersson BS; Wallerstein RO; Gutterman J; Deisseroth AB; Champlin RE
Bone Marrow Transplant; 1993 Jan; 11(1):55-9. PubMed ID: 8094309
[TBL] [Abstract][Full Text] [Related]
11. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
Alegre A; Tomás JF; Martínez-Chamorro C; Gil-Fernández JJ; Fernández-Villalta MJ; Arranz R; Díaz MA; Granda A; Bernardo MR; Escudero A; López-Lorenzo JL; Fernández-Rañada JM
Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
Webb IJ; Eickhoff CE; Elias AD; Ayash LJ; Wheeler CA; Schwartz GN; Demetri GD; Anderson KC
Transfusion; 1996 Feb; 36(2):160-7. PubMed ID: 8614968
[TBL] [Abstract][Full Text] [Related]
14. Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors.
Haas R; Hohaus S; Ehrhardt R; Goldschmidt H; Hunstein W
Bone Marrow Transplant; 1993; 11 Suppl 2():30-5. PubMed ID: 8101459
[TBL] [Abstract][Full Text] [Related]
15. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
Boiron JM; Marit G; Fabéres C; Cony-Makhoul P; Foures C; Ferrer AM; Cristol G; Sarrat A; Girault D; Reiffers J
Bone Marrow Transplant; 1993 Jul; 12(1):49-55. PubMed ID: 8104070
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
17. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
Kohno A; Takeyama K; Narabayashi M; Okamoto R; Adachi I; Tobinai K; Shimoyama M
Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
Haas R; Hohaus S; Egerer G; Ehrhardt R; Witt B; Hunstein W
Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
[TBL] [Abstract][Full Text] [Related]
20. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
